Zvezdochka LOR, spray for local use, it contains NSAIDs (Benzidamine hydrochloride) and is used in the symptomatic treatment of diseases of ENT organs and organs of the oral cavity.
Active ingredient: benzidamine hydrochloride - 45 mg; Auxiliary components: glycerol - 3.0 g, ethanol - 6.0 g, sodium saccharin - 30 mg, peppermint flavor - 30 mg, water - up to 30 ml.
Indications / Application Notes
Symptomatic pain therapy for inflammatory diseases of the oral cavity and LOP organs (of various etiologies): - gingivitis, glossitis, stomatitis (including after radiation and chemotherapy); - pharyngitis, laryngitis, tonsillitis; - candidiasis of the oral mucosa (as part of combination therapy); -calculous inflammation of the salivary glands; - after surgical interventions and injuries (tonsillectomy, jaw fractures) - after treatment and tooth extraction; - periodontal disease; In infectious and inflammatory diseases requiring systemic treatment, it is necessary to use as part of combination therapy
Hypersensitivity to benzidamine or other components of the drug, children under 3 years old.
Mode of application
The drug should be used topically after a meal. One injection, with short-term (1-2 sec.) Pressing the sprayer, corresponds to 0.255 mg of benzidamine. Topical Spray 0.15%: Adults (including elderly patients) and children over 12 years of age with 4-8 injections 2-6 times a day. Children from 6 to 12 years old - 4 injections 2-6 times a day. For children from 3 to 6 years, 1 injection for every 4 kg of body weight, but not more than 4 injections (maximum single dose) 2-6 times a day. The duration of treatment should not exceed 7 days. If, after the recommended treatment period has elapsed, no improvement has occurred or new symptoms appear, consult a doctor. Use the drug only according to the method of use and at the doses indicated in the instructions. If necessary, please consult your doctor before using the medicine.
Side effects
Classification of the incidence of side effects of the World Health Organization (WHO): very often - ≥ 1/10; often - from ≥ 1/100 to <1/10; infrequently - from ≥ 1/1000 to <1/100; rarely - from ≥ 1/10000 to <1/1000; very rarely - <1/10000; frequency unknown - cannot be estimated based on available data. Local reactions: rarely - dryness, burning in the oral cavity; Frequency unknown - numbness in the mouth. Allergic reactions: infrequently - photosensitivity: rarely - hypersensitivity reactions, skin rash, itching; very rarely - angioedema, laryngospasm; frequency unknown - anaphylactic reactions. If any of the side effects specified in the instructions are aggravated, or other side effects are noted that are not listed in the instructions, you should immediately inform your doctor.
Special instructions
When using the drug, the development of reactions is possible hypersensitivity. In this case, it is recommended to stop treatment and consult a doctor to prescribe appropriate therapy. An ulcerative lesion of the mucous membrane of the oropharynx may indicate the presence of a more serious pathology. If symptoms persist for more than 3 days, consult a doctor. Application the drug is not recommended in patients with hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs. The drug should be used with caution used in patients with a history of bronchial asthma due to the possibility of developing bronchospasm in patients with the use of the drug. Zvezdochka LOR contains low ethanol. Containing ethanol, less than 100 mg in a single dose
Release form
30 ml in a plastic bottle equipped with a protective cap with spray device made of plastic. One vial with instructions for use in a cardboard box.
Storage conditions
In the dark place at a temperature of no higher than 30 °C.
Shelf life
3 years
DANAFA PHARMACY JOINT STOCK COMPANY st. Dung Xi Thanh The 253, Da Nang City, Vietnam